There isn't a magical, one-size-fits-all solution for depression. In my practice, the goal is always finding the right tool for where you are right now. Ketamine and your standard antidepressants each have a job to do; honestly, for many of the patients I see here in Florida, the choice isn't even a binary either/or deal. [1]
The Clinical Mechanism
Your standard antidepressants—I'm talking about SSRIs like sertraline, SNRIs like venlafaxine, or atypicals like bupropion—slowly tweak your monoamine neurotransmitters. They focus on serotonin, norepinephrine, and dopamine. It’s a slow-burn process. You have to take a pill every single day to keep those levels steady. [2]
Ketamine takes a completely different route through the glutamate system. By briefly blocking NMDA receptors, it triggers a rush of BDNF—think of it like fertilizer for your brain—to help regrow synaptic connections in the prefrontal cortex. These are the areas that tend to physically shrink when someone's been dealing with chronic depression for years. [3]
How Fast Will You Feel Better?
- SSRIs and SNRIs: You're looking at 4–8 weeks for the full effect, though you might notice a small shift by week two if you're lucky.
- Ketamine: We often see a measurable mood lift within just 24 hours, and that progress usually deepens over a 4–6 week induction period.
Real-World Effectiveness
If you're dealing with mild to moderate depression and haven't tried meds before, SSRIs are a solid first step; about 50–60% of people respond well to that first prescription. But it gets tricky with treatment-resistant depression. (2024 Nature Medicine study on extended-release ketamine tablets for treatment-resistant depression) Once you’ve failed two or more antidepressants, the odds of another pill working drop significantly—meanwhile, ketamine keeps showing response rates in that 50–70% range. [1]
Side Effects
The side effect profiles couldn't be more different. In my experience, this is usually what makes a patient decide to pivot from one to the other.
- SSRIs and SNRIs can cause weight changes, sleep issues, or that 'zombie' emotional blunting; plus, sexual side effects hit up to 50% of users.
- Ketamine involves some short-term dissociation or drowsiness during the session, and maybe a little nausea or a blood pressure spike that clears up within two hours.
- Crucially, ketamine won't cause weight gain, sexual dysfunction, or that flat emotional feeling common with daily pills.
Dosing and Your Daily Life
Antidepressants mean a daily commitment, often indefinitely. Ketamine is more of an intensive project—usually 2–3 sessions a week for about 4–6 weeks—followed by a tapered maintenance schedule. Some of my patients love the 'set it and forget it' daily pill, while others hate being tethered to a bottle and prefer ketamine's structured approach.
The Bottom Line
If you're new to this, an SSRI paired with therapy is probably where we'll start; it’s effective for most and easy on the wallet. Look—ketamine becomes the clear winner when those pills have failed you, when the side effects are ruining your quality of life, or when you need relief way faster than a traditional pharmacy can provide. Sometimes, the best results come from using both together.
Available across Florida
Reset My Vitality is a Florida-licensed telehealth practice. The treatments covered in this guide are available to patients statewide, with medication shipped directly to your door. Explore the program for your city:
- Mental Health in Miami, FL
- Mental Health in Miami Beach, FL
- Mental Health in Fort Lauderdale, FL
- Mental Health in West Palm Beach, FL
- Mental Health in Boca Raton, FL
- Mental Health in Orlando, FL
- Mental Health in Tampa, FL
- Mental Health in Jacksonville, FL
- Mental Health in Naples, FL
Key Clinical Studies
A short, responsible summary of recent peer-reviewed research relevant to this topic. This is for education only, not medical advice.
Efficacy of ketamine therapy in the treatment of depression
Indian Journal of Psychiatry · 2019
Key finding: Subanesthetic ketamine (0.5 mg/kg IV) produced robust, rapid antidepressant effects that were visible immediately and largely sustained at one month in patients with depression.
Why it matters: Supports the rapid onset and structured dosing protocol used in our at-home low-dose ketamine program.
View studyExtended-release ketamine tablets for treatment-resistant depression
Nature Medicine · 2024
Key finding: 180 mg twice-weekly extended-release ketamine tablets significantly improved MADRS scores vs placebo in treatment-resistant depression, with good tolerability and mostly at-home dosing.
Why it matters: Demonstrates that controlled at-home ketamine delivery can be both safe and effective for difficult-to-treat cases.
View studyKetamine vs ECT for non-psychotic treatment-resistant major depression
New England Journal of Medicine · 2023
Key finding: Intravenous ketamine was non-inferior to electroconvulsive therapy for non-psychotic treatment-resistant depression, with roughly 55% of ketamine patients showing sustained improvement.
Why it matters: Reinforces ketamine as a credible option for patients who have not responded to traditional antidepressants.
View studyScientific References
Peer-reviewed studies and reviews cited in this article.
- [1]Glue P, et al. Extended-release ketamine tablets for treatment-resistant depression. Nat Med. 2024. View study
- [2]Yavi M, et al. Ketamine treatment for depression: a review. 2022. View study
- [3]Tully JL, et al. Ketamine treatment for refractory anxiety: A systematic review. 2022. View study
